Sell-Side Advisory · Healthcare IT & Services

Healthcare IT & Services M&A Advisory

Windsor Drake advises healthcare IT and tech-enabled healthcare services founders on the sale of their companies through institutional-grade competitive processes. We combine direct knowledge of how PE-backed healthcare IT consolidators, strategic platform companies, health systems and payor technology arms, and enterprise software vendors evaluate reimbursement model exposure, EHR integration architecture, HIPAA compliance maturity, clinical workflow depth, and the tech-enabled versus labor-intensive positioning that determines whether a company is valued on software multiples or services multiples.

Focus: Healthcare IT & Services · Revenue $5M–$100M · EBITDA $1M–$20M · US & Canada · 7 healthcare IT domains · 4–20x+ EBITDA · Senior MD-led

Request a Confidential Discussion Request a Confidential Valuation

Healthcare IT Domains

4–20x+

EBITDA Multiples

50–100+

Buyers Per Process

US & CA

Cross-Border Execution

Overview

What is healthcare IT & services M&A advisory?

Healthcare IT and services M&A advisory is sell-side investment banking for companies that sell technology and tech-enabled services to healthcare providers, payors, and health systems, RCM, EHR and practice management, patient engagement, clinical analytics, telehealth, data and interoperability, and workforce technology. It requires fluency in both B2B SaaS transaction dynamics and the reimbursement exposure, HIPAA compliance, EHR integration depth, and clinical workflow dependencies that make healthcare fundamentally different from other technology verticals.

Healthcare IT M&A is being reshaped by a structural investor pivot. PE firms are systematically shifting capital away from reimbursement-exposed provider models toward software and services platforms that support care delivery without direct reimbursement risk. Capital invested in B2B healthcare IT rose 11% year-over-year in 2024 to $14.7 billion, with deal count increasing 36%; healthcare IT M&A activity rose 26% in 2025. Francisco Partners acquired AdvancedMD for $1.1 billion; GE HealthCare acquired Intelerad for $2.3 billion; EQT acquired GeBBS for $850 million. The pattern favors companies positioned on the technology side of the spectrum.

Sector Coverage

Seven healthcare IT domains advised.

Revenue Cycle Management (RCM)

Billing, coding, claims processing, and payment collection.

EHR & Practice Management

The clinical and administrative backbone for healthcare practices.

Patient Engagement & Digital Front Door

Scheduling, intake, communication, and patient experience.

Clinical Decision Support & Analytics

Care quality and operational performance.

Telehealth & Virtual Care

Remote clinical service delivery.

Healthcare Data & Interoperability

Data exchange across fragmented healthcare systems.

Workforce Management & Staffing Technology

Technology addressing the industry’s persistent labor challenge.

Tech-Enabled vs. Labor-Intensive

The positioning decision that moves the multiple 2–3 turns.

The most consequential positioning decision in healthcare IT M&A is where the company sits on the tech-enabled versus labor-intensive spectrum. Tech-enabled platforms, where software automates clinical or administrative workflows, AI replaces manual labor, and recurring SaaS subscriptions generate 70%+ gross margins, command 12–20x+ EBITDA because they represent scalable infrastructure. Labor-intensive services companies, where revenue scales linearly with headcount and margins depend on labor arbitrage, trade at 3–8x EBITDA. The question is not what the company does but how it delivers value, through software that scales without proportional labor, or through people performing work software could eventually replace. PE firms are systematically repricing this distinction, and the gap has widened to 2–3x on the same revenue base.

Founders 12 to 18 months from a potential transaction benefit from early assessment through Windsor Drake’s exit readiness practice: HIPAA compliance audit, EHR integration depth assessment, reimbursement exposure analysis, revenue quality documentation, payor and provider concentration review, AI integration positioning, and buyer universe construction.

Who this service is for

Healthcare IT or tech-enabled healthcare services company of meaningful scale and profitability, or $1M–$20M in EBITDA

Platform delivering RCM software or services, EHR, practice management, patient engagement, clinical analytics, telehealth, healthcare data interoperability, or workforce technology

Recurring or contractual revenue model with documented provider, payor, or health system customer retention

HIPAA compliance with documented security program, BAA coverage, and data handling architecture

Founder-led or closely held ownership structure

Operating in the United States, Canada, or both

Prepared to commit to a 6–10 month structured process

Process

How the sell-side process works for healthcare IT companies.

Assessment & positioning

Deep analysis of revenue composition and recurring revenue quality (SaaS subscriptions vs. implementation vs. transaction fees vs. percentage-of-collections), gross margin architecture (the single most scrutinized metric in healthcare IT M&A), customer segmentation, reimbursement model exposure, EHR integration architecture across Epic, Oracle Health/Cerner, Meditech, athenahealth, eClinicalWorks and NextGen, HIPAA and security maturity (SOC 2 Type II, HITRUST), clinical workflow depth, AI and automation capabilities, and interoperability standards (HL7, FHIR). The output is a positioning thesis framing the company on the tech-enabled spectrum.

Buyer universe construction

Identification and qualification of 50–100+ buyers: PE-backed healthcare IT consolidators building integrated platforms (most active category), strategic platform companies filling product gaps (Waystar, athenahealth, AdvancedMD, NextGen, eClinicalWorks, Greenway, CareCloud, Veradigm), health system and payor technology arms, enterprise software companies entering healthcare (Salesforce Health Cloud, ServiceNow, Oracle Health), services companies productizing labor into software, and public healthcare IT companies seeking growth acquisitions. Each evaluated on platform architecture, specialty alignment, customer overlap, and acquisition thesis.

Controlled outreach

Direct, confidential outreach gated behind NDAs. Healthcare IT carries heightened confidentiality, provider customer lists involve HIPAA-covered organizations, and a provider client discovering its vendor is in a sale process raises data-security and compliance-continuity concerns that affect renewals. Information is released in stages protecting customer identity, pricing architecture, clinical workflow specifics, and PHI-handling details.

Indication collection & negotiation

Receipt and evaluation of indications. Healthcare IT-specific terms: whether valuation applies on ARR, revenue, or EBITDA basis (pure SaaS on ARR; blended on EBITDA; labor-intensive on lower EBITDA ranges), treatment of professional services and percentage-of-collections revenue, BAA assignment and HIPAA transfer, EHR integration maintenance commitments, clinical workflow team retention, and earnouts tied to ARR growth, retention, and AI deployment, calibrated to the healthcare procurement cycle (Q4 close for January implementation).

HIPAA, compliance & technical diligence

Coordination across financial, technical, regulatory, and compliance workstreams: HIPAA review (risk assessment, BAA inventory, breach history, safeguards, training), HITRUST or SOC 2 Type II review, product architecture (multi-tenant SaaS, EHR integration depth, FHIR/HL7 compliance, encryption), reimbursement exposure analysis, gross margin decomposition isolating software margins from services, contract review, ARR cohort retention by specialty and size, and AI validation (clinical accuracy, bias testing). The advisor resolves compliance findings before they become impediments.

Definitive agreement & close

Negotiation of the purchase agreement, including BAA assignment and HIPAA transfer, PHI continuity obligations, clinical workflow team retention, EHR integration maintenance commitments (Epic, Cerner and other certifications and APIs), customer assignment and provider notification, AI model documentation and responsible-AI representations, regulatory certification maintenance (ONC), payor contract portability, and breach-history representations. Coordination through signing and close, sequenced so healthcare IT transitions do not disrupt clinical operations or patient data security.

Considering a Sale?

Software multiples are won on margin architecture and AI evidence.

Windsor Drake runs confidential, competitive sale processes for founder-led companies. Request a confidential, no-obligation read on where your company would price and which buyers are active.

Request a Confidential Valuation Speak With an Advisor

Buyer Perspective

What buyers evaluate in healthcare IT targets.

Gross margin architecture & revenue quality

The single most consequential metric in healthcare IT M&A. Pure SaaS platforms (70–85% margins) operate with software economics; tech-enabled services (40–60%) run a hybrid model with a margin ceiling; labor-intensive services (20–35%) operate on labor arbitrage that AI is increasingly automating. Buyers decompose margin by revenue line, and the relative weight determines whether the company is valued on software multiples (12–20x+ EBITDA) or services multiples (3–8x).

Reimbursement model exposure & regulatory risk

PE investors are systematically shifting away from reimbursement-exposed businesses. Buyers assess three levels: direct exposure (revenue tied to Medicare, Medicaid, or commercial rates), indirect exposure (customers depend on reimbursement), and insulated (technology providers need regardless of payment dynamics). Insulated companies command premium multiples; the positioning thesis must explicitly address reimbursement sensitivity, or show the value proposition strengthens when reimbursement pressure rises.

EHR integration depth & clinical workflow embedding

Healthcare IT platforms must integrate with the provider’s EHR, the clinical system of record. Buyers distinguish shallow integrations (SSO, basic data transfer) from deep ones (bidirectional clinical exchange, workflow automation embedded in the EHR UI, real-time decision support). Deep Epic integration with certified APIs creates switching costs that are functionally impossible to replicate without disrupting clinical operations, and marketplace certifications (Epic App Orchard, Oracle Health Store) take months or years to obtain.

AI & automation as margin-expansion driver

AI is the primary value-creation thesis for 2026, modeled through a labor-replacement lens: ambient documentation, automated coding, prior-authorization automation, predictive denial prevention. Every manual process automated converts services-margin revenue into software-margin revenue, expanding gross margin and the multiple simultaneously. Companies that show measurable labor-replacement metrics command premiums; AI claims without production metrics face skepticism.

HIPAA compliance & security maturity

A binary qualification criterion, but depth determines whether it is an asset or a risk. Buyers assess the risk assessment, BAA coverage, HITRUST or SOC 2 Type II certification (HITRUST is the gold standard), penetration-testing and breach history, and workforce training. A company with HITRUST, clean breach history, and comprehensive BAAs is a compliance asset; gaps create valuation discounts, escrow holdbacks, and indemnification provisions.

Specialty vertical concentration & expansion

Specialty-built platforms (physical therapy, ophthalmology, dental, behavioral health) create moats horizontal platforms cannot replicate, specialty-specific templates, billing rules, and compliance configurations represent years of embedded domain knowledge. PE firms pursuing specialty rollups pay premiums for technology that already addresses their target vertical, and buyers assess whether the architecture extends to adjacent specialties without a rebuild.

Advisory Perspective

Common mistakes in healthcare IT M&A processes.

Presenting blended margins without decomposition

A company reporting 55% blended gross margins without decomposing leaves buyers to assume the worst. If those margins combine 80% SaaS with 25% professional services, the SaaS component is a premium asset masked by a services drag. Pre-process preparation must decompose margin by revenue line, isolating and highlighting the highest-margin revenue to demonstrate the company’s position on the tech-enabled spectrum.

Ignoring reimbursement exposure in the positioning thesis

Every buyer’s first question is how revenue is affected by reimbursement policy. A company that does not proactively categorize its exposure, directly exposed, indirectly exposed, or insulated, cedes the narrative to the buyer’s risk committee. For percentage-of-collections RCM models, the thesis must show resilience: stability through prior changes, contractual floors, diversified payor mix, and the counter-cyclical argument that providers invest more in RCM when margins compress.

Treating HIPAA compliance as a checkbox

Diligence goes far beyond a privacy policy. The security risk assessment must be current and documented; every customer must have a BAA that survives assignment; breach history must be documented; encryption, access controls, audit logging, and training must be provable. Gaps create escrow holdbacks, indemnification carve-outs, and valuation reductions. HITRUST certification eliminates most compliance friction and signals institutional-grade maturity.

Claiming AI capabilities without production metrics

AI is the primary valuation driver and the most overstated capability. Buyers demand production metrics: volume processed by AI versus manual labor, accuracy in production (not testing), measurable labor reduction for customers, and AI revenue contribution. A company claiming AI-powered coding without documented production accuracy and coder-hour reduction is discounted to services-level multiples regardless of marketing language.

Limiting the buyer universe to other healthcare IT companies

The buyer universe extends beyond health-IT vendors: health systems building capabilities, payors acquiring provider-performance technology, enterprise software companies (Salesforce, ServiceNow, Oracle) entering healthcare, cybersecurity companies addressing healthcare security, fintech companies solving healthcare payments, and offshore BPO companies acquiring AI to transform their labor models. Competitive tension across categories drives auction dynamics that narrow processes miss.

Illustrative Example

How a structured process creates value.

A specialty-focused RCM software and analytics platform serving orthopedic and physical therapy practices, $11.5M in ARR, 116% net revenue retention, and approximately 340 practice customers across 22 states, engaged an advisor to explore strategic alternatives. The platform combined AI-powered medical coding (94% first-pass accuracy in production across 2.1 million encounters annually), claims management, denial-prevention analytics, and benchmarking into a single SaaS platform. Gross margins were 74% on the SaaS subscription component, 62% blended including implementation. The company held HITRUST certification, maintained BAAs with all customers, and had no breach history. Deep certified integrations with athenahealth, NextGen, and eClinicalWorks served as structural switching costs; the average customer had been on the platform 3.6 years, with 96% gross retention.

The advisor positioned the company on three value layers: the AI coding automation as a labor-replacement asset (94% first-pass accuracy, documented 40% reduction in coding staff hours for customers on the automated workflow); the specialty-specific RCM intelligence (orthopedic and PT billing rules, denial patterns, and benchmarking data from 340 practices, a proprietary dataset generic platforms cannot replicate); and the EHR-integrated SaaS model with 74% software margins demonstrating a technology platform, not a services company. The buyer universe included 60+ qualified parties. Competitive tension between an RCM services company seeking to convert its 30%-margin offshore model into a 60%+ tech-enabled model and a PE-backed consolidator that valued the 340-practice footprint and proprietary dataset drove the final multiple above initial indications. The deal included cash-at-close, ARR-growth and AI-adoption earnouts at 12 and 24 months, clinical domain team retention, and EHR integration maintenance commitments. Process from engagement to signing: approximately eight months. Illustrative example only; not a specific Windsor Drake engagement.

Positioning

Why healthcare IT requires a specialized advisor.

US healthcare spending exceeds $4.8 trillion annually and is growing faster than GDP, a structural tailwind that does not exist in other technology verticals. Healthcare IT M&A activity rose 26% in 2025 with over 400 health-tech deals, driven by PE capital pivoting from reimbursement-exposed provider models toward technology platforms. Capital invested in B2B healthcare IT reached $14.7 billion in 2024; digital health funding rose 19% to $22.3 billion in 2025. Francisco Partners acquired AdvancedMD for $1.1 billion; GE HealthCare acquired Intelerad for $2.3 billion; EQT acquired GeBBS for $850 million; Qualtrics is acquiring Press Ganey for $6.75 billion.

Healthcare IT companies are valued on a wider spectrum than most B2B SaaS verticals. The spread between tech-enabled platforms (12–20x+ EBITDA with software margins) and labor-intensive services (3–8x with services margins) is the defining valuation dynamic. A fintech company is valued on transaction volume and licensing; a cybersecurity company on detection efficacy; a healthcare IT company on gross margin architecture, reimbursement exposure, EHR integration depth, AI automation, HIPAA maturity, and specialty concentration, and which side of the tech-enabled divide it falls on determines a 2–3x multiple difference. The deal mechanics, BAA assignment, PHI continuity, EHR certification maintenance, ONC compliance, payor contract portability, create closing workstreams that do not exist in EdTech, payments, or horizontal SaaS transactions. Cross-border execution between the United States and Canada further requires navigating HIPAA versus PIPEDA and provincial health-privacy law (PHIPA in Ontario, HIA in Alberta), different EHR ecosystems, and single- versus multi-payor reimbursement models.

Related Verticals

M&A advisory by vertical.

B2B SaaS

All B2B SaaS verticals

Fintech

Payments, lending, infrastructure

Cybersecurity

Security software, MSSP, GRC

EdTech SaaS

LMS, SIS, assessment

GovTech SaaS

Government technology

Home Services

Service businesses, HVAC, plumbing

Business Services

Professional, consulting, staffing

All Verticals

Complete M&A advisory

Frequently Asked Questions

Healthcare IT M&A advisory questions.

What is healthcare IT M&A advisory?

Healthcare IT M&A advisory is sell-side investment banking for companies that sell technology and tech-enabled services to healthcare providers, payors, and health systems. The advisor represents the founder in a structured sale process, building a buyer universe that spans PE-backed healthcare IT consolidators, strategic platform companies, health system technology arms, enterprise software vendors, services companies productizing into technology, and public healthcare IT companies, while managing tech-enabled versus labor-intensive positioning, HIPAA compliance documentation, EHR integration assessment, and reimbursement model exposure analysis.

How are healthcare IT companies valued?

Healthcare IT companies are valued on EBITDA multiples ranging from 4–20x+, reflecting the divide between tech-enabled platforms and labor-intensive services. Pure SaaS platforms with 70%+ gross margins, AI automation, and deep EHR integrations command 12–20x+ EBITDA. Tech-enabled services with blended 40–60% margins trade at 8–12x. Labor-intensive services trade at 3–8x. Premium drivers include gross margin architecture, AI-driven labor replacement, EHR integration depth, HIPAA maturity (HITRUST), specialty concentration, reimbursement insulation, and retention above 95%.

Why is gross margin the most important metric?

Gross margin reveals the fundamental nature of a healthcare IT business. It tells buyers whether the company is a software platform (70–85% margins that scale without proportional labor), a tech-enabled services business (40–60% with a software-plus-labor model), or a labor-intensive services company (20–35% that scales with headcount). This directly determines the multiple, software-margin companies are valued 2–3x higher than services-margin companies on the same EBITDA.

What healthcare IT domains does Windsor Drake cover?

Seven domains: Revenue Cycle Management (RCM), EHR and practice management, patient engagement and digital front door, clinical decision support and analytics, telehealth and virtual care, healthcare data and interoperability, and workforce management and staffing technology.

Who buys healthcare IT companies?

Six buyer categories: PE-backed healthcare IT consolidators building integrated platforms (most active), strategic platform companies filling product gaps (Waystar, athenahealth, AdvancedMD, NextGen, Greenway), health system and payor technology arms, enterprise software companies entering healthcare (Salesforce Health Cloud, ServiceNow, Oracle Health), services companies acquiring technology to transform labor-intensive models, and public healthcare IT companies seeking growth acquisitions.

How does AI affect healthcare IT valuations?

AI is the primary valuation driver for 2026, modeled through a labor-replacement lens: every manual process automated converts services-margin revenue into software-margin revenue, expanding gross margins and the multiple simultaneously. Companies that demonstrate production AI metrics (coding accuracy, staff-hour reductions, claims processed without human intervention) command premiums; companies claiming AI without production metrics are discounted to services-level multiples.

What size healthcare IT companies does Windsor Drake advise?

Windsor Drake advises healthcare IT and tech-enabled healthcare services companies of meaningful scale and profitability, typically with documented provider or payor relationships, HIPAA compliance programs, recurring or contractual revenue, and product-market fit sufficient for institutional-grade acquirers.

When should a healthcare IT founder engage an M&A advisor?

The optimal window is 12 to 18 months before a target transaction date. Preparation includes HIPAA audit and remediation (pursuing HITRUST if not held), EHR integration assessment, gross margin decomposition by revenue line, reimbursement exposure analysis, AI capabilities documentation with production metrics, retention analysis by specialty and size, clinical workflow team retention planning, and buyer universe construction with platform-gap analysis per acquirer.

Confidential Inquiry

Discuss a potential healthcare IT transaction.

Windsor Drake advises a limited number of healthcare IT and tech-enabled services companies each year. If you are a founder considering a sale or recapitalization in the next 12–18 months, a confidential discussion is the appropriate first step.

Request a Confidential Discussion

All inquiries are strictly confidential. No information is disclosed without written consent.